WO2006076255A3 - Method of treating or preventing microbial eye infection - Google Patents
Method of treating or preventing microbial eye infection Download PDFInfo
- Publication number
- WO2006076255A3 WO2006076255A3 PCT/US2006/000593 US2006000593W WO2006076255A3 WO 2006076255 A3 WO2006076255 A3 WO 2006076255A3 US 2006000593 W US2006000593 W US 2006000593W WO 2006076255 A3 WO2006076255 A3 WO 2006076255A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treating
- infection
- eye infection
- preventing microbial
- eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A method of treatment for treating, preventing, inhibiting or reducing microbial eye infection of eye tissue of a subject, includes administering to a subject in need of such treatment an effective amount of a composition including an antimicrobial agent including amino acid sequence LKKTET or LKKTNT, a conservative variant thereof, or an agent that stimulates production of an LKKTET or LKKTNT peptide, or a conservative variant thereof, in the tissue, so as to inhibit the infection.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64252005P | 2005-01-11 | 2005-01-11 | |
US64251605P | 2005-01-11 | 2005-01-11 | |
US60/642,516 | 2005-01-11 | ||
US60/642,520 | 2005-01-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006076255A2 WO2006076255A2 (en) | 2006-07-20 |
WO2006076255A3 true WO2006076255A3 (en) | 2007-12-13 |
Family
ID=36678103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/000593 WO2006076255A2 (en) | 2005-01-11 | 2006-01-10 | Method of treating or preventing microbial eye infection |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006076255A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011279539A1 (en) * | 2010-07-14 | 2013-03-07 | Adistem Ltd | Method of treatment of HIV or AIDS |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040617A9 (en) * | 1999-03-12 | 2003-02-27 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
US20040131626A1 (en) * | 2001-03-15 | 2004-07-08 | Goldstein Allan L. | Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
-
2006
- 2006-01-10 WO PCT/US2006/000593 patent/WO2006076255A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040617A9 (en) * | 1999-03-12 | 2003-02-27 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
US20040131626A1 (en) * | 2001-03-15 | 2004-07-08 | Goldstein Allan L. | Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
Also Published As
Publication number | Publication date |
---|---|
WO2006076255A2 (en) | 2006-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1880719A3 (en) | Composition for prophylaxis or treatment of urinary system infection and method thereof | |
BRPI0514420A (en) | peptide, variant thereof, or a pharmaceutically acceptable salt thereof, composition, use of a peptide or peptide variant, substrate, and methods of treating or preventing a microbial infection, and treating a wound in an individual | |
NZ701559A (en) | Compositions comprising povidone-iodine | |
WO2006093348A3 (en) | Method and composition for treating peripheral vascular diseases | |
EA200802166A1 (en) | STABLE PHARMACEUTICAL COMPOSITION WITH PROTECTIVE ACTION AGAINST IRRITATION (OPTIONS), METHOD FOR ITS PREPARATION AND METHOD OF TREATING CALCIUM MIMETIC WITH IT WITH HELP | |
WO2009129437A3 (en) | Methods and compositions for treating post-operative pain comprising clonidine | |
EP1945234A4 (en) | Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients | |
WO2009027820A3 (en) | Substituted-quinoxaline-type-piperidine compounds and the uses thereof | |
WO2007112000A3 (en) | Treatment of pain | |
WO2012003474A3 (en) | Compositions and methods related to protein a (spa) variants | |
WO2008089268A3 (en) | Methods and compositions for treating conditions associated with infection and/or inflammation | |
BRPI1007379B8 (en) | pharmaceutical compositions for the treatment or prevention of oral infections by e. coli | |
WO2009111064A3 (en) | Minocycline compounds and methods of use thereof | |
WO2007014253A3 (en) | Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure | |
MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
WO2010030180A3 (en) | Peptide formulations and uses thereof | |
TW200639159A (en) | Treatment of pain | |
WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
WO2006135493A3 (en) | A composition for wound healing and use thereof | |
RU2012157473A (en) | METHOD FOR IDENTIFICATION OR TREATMENT OF REACTION "TRANSPLANT AGAINST THE OWNER" | |
HK1114876A1 (en) | Arthrospira-based compositions and uses thereof | |
WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
WO2011049327A3 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
EP2889034A3 (en) | Compositions and methods of treatment comprising ceftaroline | |
EP3939599A3 (en) | Silicate containing compositions and methods of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06717756 Country of ref document: EP Kind code of ref document: A2 |